Meningitis Diagnostic Testing Market, By Test Type, By Technology, By Sample Type, By Pathogen, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Meningitis Diagnostic Testing Market size was valued at US$ 128.98 Million in 2025, expanding at a CAGR of 3.5% from 2026 to 2033.

Meningitis diagnostic testing can be defined as the process of conducting diagnostic examinations for determining whether a person has an infection involving the inflammation of the meninges, which are the protective layers around the brain and spinal cord. Meningitis tests include those that help determine the causative agents that trigger the condition so that the patient can be put under effective treatment. Some of the tests conducted as part of meningitis diagnosis include CSF analysis, blood culture, PCR tests, antigen tests, microscopic examination, and molecular methods. The major reason for conducting such tests is to ensure accurate diagnosis and early medical intervention for minimizing the adverse effects associated with the condition. As a result of the increasing importance of disease detection and monitoring, meningitis diagnostic testing has become essential in the modern health care system and institutions across the world.

Meningitis Diagnostic Testing Market- Market Dynamics

Advancements in nanotechnology and microfabrication to propel market demand

The rise in numbers of patients diagnosed with meningitis across the world represents a significant factor that positively affects the development of the Meningitis Diagnostic Testing market due to the need to diagnose this disease timely in order to treat it in a timely manner. Meningitis is a significant health issue due to its high levels of mortality and morbidity, along with some possible outcomes related to brain damage caused by this disease. According to WHO, meningitis continues to represent an urgent health challenge across the globe, being widespread in poor countries as well as in the African meningitis belt. Some official statistics confirm this problem. For instance, as stated in reports provided by WHO, every year, approximately 2.5 million people get infected with meningitis, including 1.6 million who have bacterial meningitis and 240,000 deaths annually. What is more, approximately 20% of patients have some serious disabilities related to hearing impairment, memory losses, and even brain complications. WHO developed its global strategy aimed at fighting with meningitis until 2030.

Meningitis Diagnostic Testing Market- Segmentation Analysis:

The Global Meningitis Diagnostic Testing Market is segmented on the basis of Test Type, Technology, Sample Type, Pathogen, End-User, and Region.

The market is divided into six categories based on test type: Latex Agglutination Tests, PCR Assay, Lateral-Flow Assay, CRISPR-based Assay, Culture Test and ELISA Tests. The PCR Assay are likely to dominates the meningitis diagnostic testing market. It is attributed to the capability of offering fast, precise, and accurate identification of pathogens that cause meningitis. The PCR assay identifies bacteria, virus, or fungi present within CSF or other sample types collected from patients with the disease. There is a growing need to identify meningitis pathogens early enough to allow prompt diagnosis and initiation of treatment, especially when patients are at risk of death from the disease.

The market is divided into four categories based on pathogen: Bacterial, Fungal, Parasitic and Viral. The bacterial might be holding a majority of market share. This increase may be associated with the significant effects of bacterial infections on the health of patients, as well as the need for accurate and fast diagnostics. Bacterial meningitis is characterized by very high levels of risk both regarding mortality and morbidity, with such complications as hearing loss, brain damage, and intellectual disability sometimes developing due to the development of this disease. There has been a great increase in cases of bacterial infection from Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae, which necessitates innovative technologies for diagnosing diseases.

Meningitis Diagnostic Testing Market- Geographical Insights

North America is likely to lead the meningitis diagnostic testing market. Its growth can be attributed to the fact that it possesses superior health care infrastructure, extensive application of molecular diagnostic techniques, and a highly focused approach towards infectious diseases surveillance. The North America region has been benefiting from extensive health care networks, advanced clinical laboratories, and extensive research & development activities in the field of health care, which contribute towards the efficient diagnosis and management of meningitis patients. Increased awareness on the part of the health care practitioners about the importance of early diagnosis along with the availability of advanced diagnostic tests like polymerase chain reaction tests, multiplex molecular diagnostic panels, and automated laboratories is boosting the volumes of diagnostic tests performed in the region. Furthermore, the health organizations like CDC and PHAC monitor meningitis cases and support vaccine programs and disease surveillance initiatives, which has resulted in an increased demand for meningitis diagnostic tests.

US Meningitis Diagnostic Testing Market- Country Insights

In the region, the US might be capturing the largest market share. Growth in the sector has been supported by ongoing advancements in technology. Availability of high-tech diagnostics like PCR testing has revolutionized the way doctors detect meningitis as they can now identify pathogens more quickly than before. Moreover, awareness campaigns about the symptoms linked to meningitis have urged more people to seek medical assistance, thus creating opportunities for the market in this segment.

Meningitis Diagnostic Testing Market- Competitive Landscape:

The meningitis diagnostic testing market is known for its high level of competition involving international diagnostic service providers, molecular diagnostic technology suppliers, clinical laboratories solutions makers, and biotechnological firms. Main competitive drivers include technical innovation, accuracy, speed of the procedure, portfolio diversity, regulatory approval, and distribution on an international level. Currently, many participants are making efforts aimed at developing cutting-edge molecular diagnostic systems, multiplex PCR kits, rapid antigen detection tests, and automated laboratory solutions that would allow identifying pathogens responsible for meningitis much faster and with higher precision. Increasing demand for quick diagnosis of meningitis contributes to greater spending on R&D.

Recent Developments:

In February 2024, QIAGEN announced the launch of two syndromic testing panels for its QIAstat-Dx instruments in India, including the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, which join the Respiratory SARS-CoV-2 Panel that had been authorized for emergency use in 2020 first time. The panels have received regulatory approval from the Central Drugs Standard Control Organization (CDSCO), enabling healthcare providers in India to diagnose patients accurately, faster, and easier.

In September 2024, Thermo Fisher Scientific announced the expansion of its bioanalytical laboratory services in Europe. This initiative aimed to enhance its capabilities in supporting the growing demand for bioanalytical testing across various sectors, including pharmaceuticals and biotechnology. The expansion included the addition of state-of-the-art technologies and an increase in laboratory capacity, which positioned the company to serve its clients better and improve turnaround times for critical testing services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

QIAGEN N.V.
BD
Hologic Inc.
Bio-Rad Laboratories
Seegene Inc.
ELITechGroup
F. Hoffmann-La Roche Ltd.
GenMark Diagnostics
bioMerieux
IMMY
DiaSorin S.p.A.
Oxford Nanopore Technologies
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Trinity Biotech
Tosoh Corporation
Meridian Bioscience
Quanterix Corporation
Others

GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033

Latex Agglutination Tests
PCR Assay
Lateral-Flow Assay
CRISPR-based Assay
Culture Test
ELISA Tests

GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

Molecular Diagnostics
Microbiology/Culture
Immunoassays
Next-Generation Sequencing

GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2020 - 2033

Cerebrospinal Fluid (CSF)
Nasopharyngeal Swab
Blood/Serum
Others

GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY PATHOGEN- MARKET ANALYSIS, 2020 - 2033

Bacterial
Fungal
Parasitic
Viral

GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033

Hospitals
Academic & Research Labs
Diagnostic Centers
Others

GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV6709

1. Meningitis Diagnostic Testing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Meningitis Diagnostic Testing Market Snippet by Test Type
- 2.1.2. Meningitis Diagnostic Testing Market Snippet by Technology
- 2.1.3. Meningitis Diagnostic Testing Market Snippet by Sample Type
- 2.1.4. Meningitis Diagnostic Testing Market Snippet by Pathogen
- 2.1.5. Meningitis Diagnostic Testing Market Snippet by End-User
- 2.1.6. Meningitis Diagnostic Testing Market Snippet by Country
- 2.1.7. Meningitis Diagnostic Testing Market Snippet by Region
2.2. Competitive Insights

3. Meningitis Diagnostic Testing Key Market Trends

3.1. Meningitis Diagnostic Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Meningitis Diagnostic Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Meningitis Diagnostic Testing Market Opportunities
3.4. Meningitis Diagnostic Testing Market Future Trends

4. Meningitis Diagnostic Testing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Meningitis Diagnostic Testing Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Meningitis Diagnostic Testing Market Landscape

6.1. Meningitis Diagnostic Testing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Meningitis Diagnostic Testing Market - By Test Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Test Type, 2025 & 2033 (%)
- 7.1.2. Latex Agglutination Tests
- 7.1.3. PCR Assay
- 7.1.4. Lateral-Flow Assay
- 7.1.5. CRISPR-based Assay
- 7.1.6. Culture Test
- 7.1.7. ELISA Tests

8. Meningitis Diagnostic Testing Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
- 8.1.2. Molecular Diagnostics
- 8.1.3. Microbiology/Culture
- 8.1.4. Immunoassays
- 8.1.5. Next-Generation Sequencing

9. Meningitis Diagnostic Testing Market - By Sample Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Sample Type, 2025 & 2033 (%)
- 9.1.2. Cerebrospinal Fluid (CSF)
- 9.1.3. Nasopharyngeal Swab
- 9.1.4. Blood/Serum
- 9.1.5. Others

10. Meningitis Diagnostic Testing Market - By Pathogen

10.1. Overview
- 10.1.1. Segment Share Analysis, By Pathogen, 2025 & 2033 (%)
- 10.1.2. Bacterial
- 10.1.3. Fungal
- 10.1.4. Parasitic
- 10.1.5. Viral

11. Meningitis Diagnostic Testing Market - By End-User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End-User, 2025 & 2033 (%)
- 11.1.2. Hospitals
- 11.1.3. Academic & Research Labs
- 11.1.4. Diagnostic Centers
- 11.1.5. Others

12. Meningitis Diagnostic Testing Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Meningitis Diagnostic Testing Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Meningitis Diagnostic Testing Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Meningitis Diagnostic Testing Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Meningitis Diagnostic Testing Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Meningitis Diagnostic Testing Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Meningitis Diagnostic Testing Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. QIAGEN N.V.
- 13.2.2. BD
- 13.2.3. Hologic Inc.
- 13.2.4. Bio-Rad Laboratories
- 13.2.5. Seegene Inc.
- 13.2.6. ELITechGroup
- 13.2.7. F. Hoffmann-La Roche Ltd.
- 13.2.8. GenMark Diagnostics
- 13.2.9. bioMerieux
- 13.2.10. IMMY
- 13.2.11. DiaSorin S.p.A.
- 13.2.12. Oxford Nanopore Technologies
- 13.2.13. Abbott
- 13.2.14. Danaher
- 13.2.15. Siemens Healthineers
- 13.2.16. Thermo Fisher Scientific
- 13.2.17. Trinity Biotech
- 13.2.18. Tosoh Corporation
- 13.2.19. Meridian Bioscience
- 13.2.20. Quanterix Corporation
- 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us